相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Imeglimin increases glucose-dependent insulin secretion and improves β-cell function in patients with type 2 diabetes
G. Pacini et al.
DIABETES OBESITY & METABOLISM (2015)
Imeglimin Normalizes Glucose Tolerance and Insulin Sensitivity and Improves Mitochondrial Function in Liver of a High-Fat, High-Sucrose Diet Mice Model
Guillaume Vial et al.
DIABETES (2015)
The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy
Pascale Fouqueray et al.
DIABETES CARE (2014)
The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
Pascale Fouqueray et al.
DIABETES CARE (2013)
American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
Alan Garber et al.
Endocrine Practice (2013)
Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians
Amir Qaseem et al.
ANNALS OF INTERNAL MEDICINE (2012)
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Silvio E. Inzucchi et al.
DIABETES CARE (2012)
Imeglimin, a novel glimin oral antidiabetic, exhibits a good efficacy and safety profile in type 2 diabetic patients
V. Pirags et al.
DIABETES OBESITY & METABOLISM (2012)
Imeglimin - A New Oral Anti-Diabetic that Targets the Three Key Defects of Type 2 Diabetes
Pascale Fouqueray et al.
JOURNAL OF DIABETES & METABOLISM (2011)
分享论文
